S&R Farmaceutici » S&R Informs

Oct

NL|15 – 21 October 2016

Today REVIFAST®CARDIO was presented to all pharmaceutical representatives, the new product by S&R Farmaceutici is the brainchild of its Research and Development Division and will further enrich the Company's extensive treatment offering.

by S&R Farmaceutici in Newsletter, Uncategorized 0 comments

Sep

NL|14 – 16 September 2016

The innovative results of S&R Farmaceutici research Barely a year on from its début on the pharmaceutical market, S&R Farmaceutici is ready to launch 2 new and highly innovative products stemming from the work of its Research and Development Division...

by S&R Farmaceutici in Newsletter 0 comments

Sep

22nd IFFS World Congress

We will participate in the 22nd congress of the international federation of fertility societies.

by S&R Farmaceutici in Group news 0 comments

Jul

NL|13 – 26 July 2016

The role of Communication in the Pharmaceutical industry remains the main source of information on pharmaceuticals in the medical sector...

by S&R Farmaceutici in Newsletter 0 comments

Jul

NL|12 – 20 July 2016

The expansion plan abroad of S&R Farmaceutici is now under way: the company is successfully concluding the first part of its foreign market penetration plan, thanks to the definition of agreements with important distributors of the sector.

by S&R Farmaceutici in Newsletter 0 comments

Jul

NL|11 – 15 July 2016

The CME Course "VAGINAL INFECTIONS AND ANAEMIA IN GYNAECOLOGY AND OBSTETRICS" came to a close a few days ago and took place at the new Minerva Auditorium of S&R Farmaceutici.

by S&R Farmaceutici in Newsletter 0 comments

Jul

Bioinformatics Course 2016

Dr. Bernard Fioretti together with his collaborator Dr. Francesco Ragonese participated in the course “Bioinformatics for everyone and everything: genomics, epigenomics, transcriptomics” which took place in Udine from 28th June until 1st July 2016 at the University of Udine...

by S&R Farmaceutici in Group news 0 comments